Company Performance Metrics
- Colleen Tupper: EVP and Chief Financial OfficerPast Role: Takeda, Senior Vice President and CFO in U.S. Business Unit
- Michael T. Heffernan: President , CEO & Chairman of the BoardPast Role: CSL, President / CEO (PhyMatrix)
Collegium Pharmaceutical is a specialty pharmaceutical company focused on the development of proprietary, late-stage pharmaceutical products. These products address the growing problems associated with non-medical use and abuse of prescription drugs through formulation based improvements protected by intellectual property (IP). Collegium is focused
on building a portfolio of products for the treatment of chronic pain that possess tamper-resistant features and provide extended-release delivery using its patent-protected DETERx formulation platform.